These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22390678)

  • 1. New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.
    Bou Samra E; Moreaux J; Vacheret F; Mills K; Rufflé F; Chiesa J; Piquemal D; Boureux A; Lavabre-Bertrand T; Jourdan E; Commes T
    Br J Haematol; 2012 May; 157(3):347-56. PubMed ID: 22390678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
    Bresolin S; Zecca M; Flotho C; Trentin L; Zangrando A; Sainati L; Stary J; de Moerloose B; Hasle H; Niemeyer CM; Te Kronnie G; Locatelli F; Basso G
    J Clin Oncol; 2010 Apr; 28(11):1919-27. PubMed ID: 20231685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
    Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
    J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
    Ngo NT; Lampert IA; Naresh KN
    Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V; Trouplin V; Roquain J; Adélaïde J; Carbuccia N; Esterni B; Finetti P; Murati A; Arnoulet C; Zerazhi H; Fezoui H; Tadrist Z; Nezri M; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
    Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
    Bacher U; Haferlach T; Schnittger S; Kreipe H; Kröger N
    Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of chronic myelomonocytic leukemia.
    Catalano L; Improta S; de Laurentiis M; Molica S; Majolino I; Musto P; Fragasso A; De Placido S; Rotoli B
    Haematologica; 1996; 81(4):324-9. PubMed ID: 8870376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.